#Takeda

New York, USA, July 27, 2023 (GLOBE NEWSWIRE) -- Non-small Cell Lung Cancer Market is Projected to Boost by 2032, Predicts DelveInsight | Key Companies Working in Space - AstraZeneca,…

Note that some links may require subscriptions. More than 61,000 Europeans died…

— Publication shows FRESCO-2 demonstrated treatment with fruquintinib reduced the risk of death by 34% in previously treated metastatic colorectal cancer (0.66 HR) — — Data support…

<!-- Name:DistributionId Value:8847048 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

<!-- Name:DistributionId Value:8827503 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

<!-- Name:DistributionId Value:8805367 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

This section is Partnership Content supplied The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients.…

This section is Partnership Content supplied The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients.…

This section is Partnership Content supplied The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients.…

Accelerating the path from diagnosis to available treatments for rare metabolic and rare neurodegenerative diseases CENTOGENE and Takeda extend contract to continue providing access to…